$14.740
+0.582 (+3.95%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HCM por análisis de gráficos similares
Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.65 (-0.58%). The 1-week path is $14.54 (-1.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de HUTCHMED (China) Ltd?
HUTCHMED (China) Ltd is a good buy right now due to its current price of $14.05, which is below the analyst price targets of $16 to $18.50, indicating potential upside. The forward P/E ratio of 18.08 suggests reasonable valuation compared to its growth prospects, especially following the licensing agreement with GSK that could enhance revenue streams. However, the main risk is the high P/E ratio of 1239.37, indicating potential overvaluation if growth does not materialize as expected.
HCM cerró en $14.74 el Tuesday, tras subir +3.95%
HUTCHMED (China) Ltd (HCM) last closed at $14.74, gaining +3.95%. These facts feed the 1-day and 1-week HCM price prediction above.
Consenso de analistas
HUTCHMED (China) Ltd (HCM): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de HUTCHMED (China) Ltd (HCM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HCM, ordenadas por similitud.
Análisis de estacionalidad de HCM
Historically the probability of a positive October return for HCM is 83.33%. October offers the highest probability of a positive month at 83.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.